F13A1 enhances temozolomide resistance in glioblastoma via activation of the NF-κB signalling pathway
Scientific Reports, Published online: 06 September 2026; doi:10.1038/s41598-026-70219-9 F13A1 enhances temozolomide resistance in glioblastoma via activation of the NF-κB signalling pathway
We haven't written up this one. Scientific Reports has the full story — the link below goes straight to it.